Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061792) titled 'Genetic Mutation Analysis of Lung Cancer Using Intraoperative Tumor Specimens' on June 3.
Study Type:
Observational
Primary Sponsor:
Institute - Jichi Medical University Saitama Medical Center
Condition:
Condition - Lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - Feasibility of multi-gene mutation testing using lung cancer specimens immediately preserved in RNA stabilization solution after surgical resection.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - 1) Patients aged 20 years or older at the time informed consent was obtained.
2) Patients who underwent surgical treatment for lung cancer.
3) Patients whose preoperative biopsy specimens, intraoperative RNA-preserved specimens, intraoperative FFPE specimens, and/or postoperative FFPE specimens were examined by multigene mutation testing under routine clinical practice covered by health insurance.
4) Patients from whom written informed consent for participation in this study was obtained.
Key exclusion criteria - Pattens who do not fulfill the inclusion criteria.
Target Size - 800
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2024 Year 12 Month 17 Day
Date of IRB - 2025 Year 03 Month 13 Day
Anticipated trial start date - 2025 Year 03 Month 13 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068104
Disclaimer: Curated by HT Syndication.
